Related Experiment Video
Updated: Jun 23, 2026
Identification of Sleeping Beauty Transposon Insertions in Solid Tumors using Linker-mediated PCR
Published on: February 1, 2013
Identification of PDE4D as a proliferation promoting factor in prostate cancer using a Sleeping Beauty
Eric P Rahrmann1, Lara S Collier, Todd P Knutson
1Department of Genetics, Cell Biology, and Development and Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Abstract:
Retroviral and transposon-based mutagenesis screens in mice have been useful for identifying candidate cancer genes for some tumor types. However, many of the organs that exhibit the highest cancer rates in humans, including the prostate, have not previously been amenable to these approaches. This study shows for the first time that the Sleeping Beauty transposon system can be used to identify candidate prostate cancer genes in mice. Somatic mobilization of a mutagenic transposon resulted in focal epithelial proliferation and hyperplasia in the prostate. Efficient methods were established to identify transposon insertion sites in these lesions, and analysis of transposon insertions identified candidate prostate cancer genes at common insertion sites, including Pde4d. PDE4D was also overexpressed in human prostate cancer patient samples and cell lines, and changes in PDE4D mRNA isoform expression were observed in human prostate cancers. Furthermore, knockdown of PDE4D reduced the growth and migration of prostate cancer cells in vitro, and knockdown of PDE4D reduced the growth and proliferation rate of prostate cancer xenografts in vivo. These data indicate that PDE4D functions as a proliferation promoting factor in prostate cancer, and the Sleeping Beauty transposon system is a useful tool for identifying candidate prostate cancer genes.
Insights
The Sleeping Beauty transposon system successfully identified prostate cancer genes in mice, revealing PDE4D as a key proliferation factor. This breakthrough offers a new tool for prostate cancer research.
Area of Science:
- Genetics
- Cancer Biology
- Molecular Biology
Background:
- Retroviral and transposon-based screens identify cancer genes but have limitations for certain organs.
- The prostate gland, with high human cancer rates, has lacked effective genetic screening methods.
- Previous approaches were not suitable for identifying prostate cancer genes in mice.
Purpose of the Study:
- To establish the Sleeping Beauty transposon system for identifying prostate cancer genes in mice.
- To investigate the role of identified genes in prostate cancer development and progression.
- To validate candidate genes using human prostate cancer samples and cell lines.
Main Methods:
- Somatic mobilization of a mutagenic Sleeping Beauty transposon in mice.
- Identification of transposon insertion sites in prostate epithelial lesions.
- Analysis of gene expression and functional validation of candidate genes (e.g., PDE4D) in vitro and in vivo.
Main Results:
- The Sleeping Beauty system induced prostate epithelial proliferation and hyperplasia.
- Common insertion sites identified candidate prostate cancer genes, including Pde4d.
- PDE4D was overexpressed in human prostate cancer, and its knockdown inhibited cancer cell growth and migration.
Conclusions:
- The Sleeping Beauty transposon system is effective for identifying prostate cancer genes in mice.
- PDE4D is a proliferation-promoting factor in prostate cancer, suggesting its potential as a therapeutic target.
- This study provides a novel platform for prostate cancer gene discovery.
